Barclays PLC Amicus Therapeutics, Inc. Call Options Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $1.03 Million - $1.34 Million	114,000 New	114,000 $1.13 Million
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $816,039 - $2.12 Million	-88,700 Reduced 99.66%	300 $3,000
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $882,280 - $1.16 Million	80,500 Added 947.06%	89,000 $1.11 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.4 Million - $1.83 Million	-106,900 Reduced 92.63%	8,500 $133,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $1.35 Million - $1.82 Million	115,400	115,400 $1.74 Million

278

324M

260K

261K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.